Literature DB >> 23523146

Correlation of conventional thrombelastography and rapid thrombelastography in trauma.

Tim H Lee1, Belinda H McCully, Samantha J Underwood, Bryan A Cotton, Mitchell J Cohen, Martin A Schreiber.   

Abstract

BACKGROUND: Conventional thrombelastography has been in use for over 6 decades and provides a functional assay of coagulation. Rapid thrombelastography was developed to provide more rapid comprehensive analysis of coagulation status in an emergency setting. The purpose of this study was to determine the correlation of rapid thrombelastographic values with conventional thrombelastographic values in trauma patients.
METHODS: We performed a prospective study on trauma patients at a university level 1 trauma center. Conventional thrombelastography and rapid thrombelastography were performed on 190 consecutive major trauma patients upon admission between 2010 and 2012. Conventional thrombelastographic and rapid thrombelastographic parameters were analyzed using bivariate analysis with Pearson correlation. Group comparisons were performed using the Mann-Whitney U test.
RESULTS: Patients were predominantly male (71.6%, P < .05) with a median Injury Severity Score of 17 (range 10 to 29) and a median age of 43 years (range 29 to 53 years). There were significantly more patients with blunt trauma than penetrating trauma (72% vs 28%, P < .05). There was a strong correlation between the rapid thrombelastographic and conventional thrombelastographic maximal amplitude value, which represents platelet function (r = .80). There was a moderate correlation between the G (overall clot strength, r = .70), k (speed of clot formation, r = .66), and α-angle (r = .38), which reflects the degree of fibrin cross-linking. Lysis at 30 minutes correlated poorly (r = .19).
CONCLUSIONS: Overall, there is a strong correlation between rapid thrombelastography and conventional thrombelastography in terms of overall clot strength and platelet function. There is a moderate correlation in assessing the degree of fibrin cross-linking and a poor correlation in evaluating thrombolysis. These correlations should be considered when evaluating coagulation status using rapid thrombelastography.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23523146     DOI: 10.1016/j.amjsurg.2013.01.016

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  5 in total

1.  Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonists.

Authors:  Francesco Franchi; Jafri Syed Hammad; Fabiana Rollini; Antonio Tello-Montoliu; Ronakkumar Patel; Andrew Darlington; Dale F Kraemer; Jung Rae Cho; Christopher DeGroat; Mona Bhatti; Mohamad Taha; Dominick J Angiolillo
Journal:  J Thromb Thrombolysis       Date:  2015-07       Impact factor: 2.300

Review 2.  Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma: descriptive systematic review.

Authors:  Luis Teodoro Da Luz; Bartolomeu Nascimento; Ajith Kumar Shankarakutty; Sandro Rizoli; Neill Kj Adhikari
Journal:  Crit Care       Date:  2014-09-27       Impact factor: 9.097

3.  Increased expressions of CD123, CD63, CD203c, and Fc epsilon receptor I on blood leukocytes of allergic asthma.

Authors:  Hua Xie; Liping Chen; Huiyun Zhang; Junling Wang; Yanyan Zang; Mengmeng Zhan; Fangqiu Gu; Shunlan Wang; Shaoheng He
Journal:  Front Mol Biosci       Date:  2022-08-11

4.  A Pilot Study of Viscoelastic Monitoring in Pediatric Trauma: Outcomes and Lessons Learned.

Authors:  Bola Aladegbami; Pamela M Choi; Martin S Keller; Adam M Vogel
Journal:  J Emerg Trauma Shock       Date:  2018 Apr-Jun

5.  Rapid thrombelastography predicts perioperative massive blood transfusion in patients undergoing coronary artery bypass grafting: A retrospective study.

Authors:  Chenyao Lin; Yourong Fu; Shuang Huang; Shuimei Zhou; Changxin Shen
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.